Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biomarin
Biomarin
4 big biopharma deals we might see in 2015
BioPharma Dive
Mon, 04/6/15 - 10:51 am
M&A
Merck
Jazz Pharmaceuticals
Shire
Biomarin
Gilead Sciences
Seattle Genetics
Pfizer
Celgene
Biotech's next buzz: Gene therapy?
CNBC
Tue, 03/31/15 - 03:59 pm
biotech
gene therapy
Spark Therapeutics
Biomarin
Avalanche Biotechnologies
Shire, BioMarin and the snowball effect of buyout rumors
Fierce Biotech
Fri, 03/27/15 - 12:05 pm
Shire
Biomarin
M&A
The Biotech Selloff: It’s Déjà Vu All Over Again
Barron's
Thu, 03/26/15 - 10:13 am
biotech
Alnylam
Biomarin
Incyte
Isis Pharmaceuticals
Vertex Pharmaceuticals
The Top 10 Biotech Companies In The U.S.
Forbes
Fri, 03/20/15 - 01:13 pm
biotech
Gilead Sciences
Amgen
Celgene
Biogen Idec
Regeneron
Alexion
Vertex Pharmaceuticals
Illumina
Biomarin
Agilent
The Top 10 Biotech Companies In The U.S.
Forbes
Fri, 03/6/15 - 11:43 am
biotech
Gilead Sciences
Amgen
Celgene
Biogen Idec
Regeneron
Alexion
Vertex Pharmaceuticals
Illumina
Biomarin
Agilent
The Next 3 Likely Biotech Buyout Candidates
24/7 Wall St
Fri, 03/6/15 - 08:38 am
biotech
Biomarin
Bluebird Bio
Incyte
M&A
BioMarin To Report Revenue In-line With Consensus, Wedbush Says
Benzinga
Sat, 02/21/15 - 10:27 am
Biomarin
earnings
Rare feat: BioMarin rewrites playbook for small-market drug approvals
Bizjournals.com
Tue, 01/27/15 - 09:41 am
Biomarin
orphan drugs
BMN-190
Batten disease
Booming biotechs bank $2.7B in follow-on cash
Fierce Biotech
Fri, 01/23/15 - 03:38 pm
biotech
Prosensa
Biomarin
Zafgen
Alnylam
Auspex
Puma Biotechnology
Arena Pharmaceuticals
Radius Health
Intrexon
BioMarin CEO Angers Sarepta CEO With Slides Comparing Trial Data
WSJ Pharmalot
Sat, 01/17/15 - 11:01 am
Biomarin
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Biotech Rivalry Gets Nasty in Mudslinging Battle Over Data
Bloomberg
Thu, 01/15/15 - 09:28 pm
Sarepta Therapeutics
Biomarin
Duchenne Muscular Dystrophy
Update: BioMarin To Acquire Prosensa Holding N.V.
Seeking Alpha
Thu, 01/15/15 - 12:03 pm
Biomarin
Prosensa
M&A
Shire’s Next Targets Could Be on This List: Real M&A
Bloomberg
Wed, 01/14/15 - 10:00 am
Shire
M&A
PTC Therapeutics
SynaGeva BioPharma
Retrophin
Ultragenyx
Vertex Pharmaceuticals
Biomarin
BioMarin CEO Sees Big Future For Prosensa Drug
Investors.com
Wed, 12/24/14 - 08:58 am
Biomarin
Prosensa
drisapersen
Duchenne Muscular Dystrophy
J.P. Morgan's 6 Top Biotech and Pharmaceuticals Stocks to Buy in 2015
TheStreet.com
Mon, 12/22/14 - 09:47 am
Alexion
Biomarin
Bristol-Myers Squibb
Jazz Pharmaceuticals
Valeant Pharmaceuticals
Illumina
BioMarin Expands Reach By Buying Prosensa for Up to $840 Million
TheStreet.com
Mon, 11/24/14 - 09:42 am
Biomarin
Prosensa
M&A
The top 10 most expensive drugs of 2013
Fierce Pharma
Tue, 10/14/14 - 10:05 am
drug pricing
Soliris
Alexion
Naglazyme
Biomarin
Kalydeco
Vertex
Cinryze
Shire
Sprycel
Bristol-Myers Squibb
Pomalyst
Celgene
Xyrem
Jazz Pharmaceuticals
Erbitux
Merck KGaA
Revlimid
Questcor
Mallinckrodt
H.P. Acthar Gel
5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential
24/7 Wall St
Thu, 09/25/14 - 09:21 am
orphan drugs
Alnylam
Biomarin
Alexion
Isis Pharmaceuticals
Vertex Pharmaceuticals
BioMarin's Q1 Loss Shrinks 79% Due to Higher Rare Disease Drug Sales
Motley Fool
Fri, 05/2/14 - 08:38 am
Biomarin
earnings
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »